{"product_id":"staar-business-model-canvas","title":"STAAR Surgical Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSTAAR Surgical's Business Model Unveiled\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic blueprint behind STAAR Surgical's innovative business model. This comprehensive Business Model Canvas details how they create value through advanced vision correction solutions and capture market share.  Discover their key partners, customer segments, and revenue streams.\u003c\/p\u003e\n\u003cp\u003eDive into the actionable insights of STAAR Surgical's complete Business Model Canvas. This downloadable resource lays bare their value proposition, cost structure, and key activities, offering a clear roadmap to their success. Perfect for anyone seeking to understand market-leading strategies.\u003c\/p\u003e\n\u003cp\u003eSee how STAAR Surgical effectively delivers its groundbreaking ophthalmic products. This full Business Model Canvas breaks down their customer relationships, channels, and competitive advantages. Download it to gain a competitive edge in your own business planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOphthalmic Surgeons and Clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical's success hinges on its deep relationships with ophthalmic surgeons and clinics worldwide. These professionals are the gatekeepers for their implantable Collamer Lens (ICL) products, directly influencing patient adoption and the actual implantation process.\u003c\/p\u003e\n\u003cp\u003eThe company actively engages these partners through comprehensive training programs and ongoing clinical support, ensuring they are proficient with the EVO ICL. This collaborative approach, exemplified by partnerships with practices like SharpeVision and IQ Laser Vision, is vital for expanding the reach and acceptance of their vision correction technology.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical relies heavily on a network of international and regional distributors to reach its global customer base, particularly given its substantial sales outside the United States. These partners are crucial for managing inventory, handling logistics, and securing local market access, which is fundamental to their market penetration strategy.\u003c\/p\u003e\n\u003cp\u003eThe performance of these distributors directly impacts STAAR Surgical's reported sales, as evidenced by recent challenges in China where distributor inventory levels played a significant role. For instance, in the first quarter of 2024, STAAR Surgical reported net sales of $315.7 million, a figure that can be influenced by the purchasing and inventory decisions of its distributor network.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch Institutions and Universities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical actively partners with research institutions and universities. These collaborations are vital for conducting ongoing clinical trials and studies, which are critical for advancing the understanding and application of their implantable collamer lens (ICL) technology. This deepens the scientific foundation supporting their products.\u003c\/p\u003e\n\u003cp\u003eThese academic partnerships are instrumental in generating new clinical data and peer-reviewed publications. Such evidence is crucial for demonstrating the long-term safety and efficacy of STAAR's lenses, bolstering confidence among both surgeons and patients. For instance, the company's commitment to research is underscored by initiatives like STAAR University, launched in April 2024, which offers surgeons access to valuable data and resources designed to enhance their clinical confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Equipment Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSTAAR Surgical collaborates with technology and equipment providers to ensure their Implantable Collamer Lens (ICL) procedures integrate smoothly into existing eye care practices. This involves partnerships that streamline the planning and ordering of ICLs.\u003c\/p\u003e\n\u003cp\u003eThese collaborations often include showcasing advanced diagnostic technology within STAAR's Experience Centers, allowing clinicians to see firsthand how these tools enhance the ICL patient journey. For instance, the integration of advanced imaging systems can improve pre-operative assessments, leading to better patient selection and outcomes.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiagnostic Equipment Integration:\u003c\/strong\u003e Partnerships with manufacturers of OCT (Optical Coherence Tomography) and topography devices ensure compatibility and data sharing for precise ICL planning.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgical Technology Providers:\u003c\/strong\u003e Collaborations with companies offering advanced phacoemulsification or femtosecond laser platforms facilitate seamless surgical workflows for ICL implantation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExperience Center Showcases:\u003c\/strong\u003e STAAR leverages partnerships to demonstrate the latest diagnostic and surgical technologies in their centers, highlighting the benefits for ophthalmic practices.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustry Associations and Professional Societies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSTAAR Surgical actively engages with key industry associations like the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract \u0026amp; Refractive Surgeons (ESCRS). These partnerships are crucial for staying informed about emerging ophthalmic trends and advancements.\u003c\/p\u003e\n\u003cp\u003eThrough participation in conferences and educational initiatives organized by these societies, STAAR Surgical effectively promotes its innovative lens technologies. This engagement also solidifies their visibility and reputation within the global ophthalmic community.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndustry Trend Monitoring:\u003c\/strong\u003e Access to the latest research and discussions at ASCRS and ESCRS meetings provides STAAR Surgical with critical insights into market needs and technological evolution.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTechnology Promotion:\u003c\/strong\u003e Presenting clinical data and product innovations at these prominent forums directly showcases the benefits of STAAR's EVO Visian ICL to a targeted audience of eye care professionals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommunity Building:\u003c\/strong\u003e Maintaining a strong presence in these professional societies fosters relationships with key opinion leaders and potential collaborators, enhancing brand loyalty and market penetration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOphthalmic Partnerships Drive Global Sales Success\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical's key partnerships extend to ophthalmic distributors globally, essential for market access and sales execution. These partners manage inventory and logistics, directly influencing sales figures. For example, in Q1 2024, STAAR reported net sales of $315.7 million, a performance tied to distributor network activity.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003eImpact Example (2024 Data)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOphthalmic Surgeons \u0026amp; Clinics\u003c\/td\u003e\n\u003ctd\u003eEnd-users, patient advocates, implantation experts\u003c\/td\u003e\n\u003ctd\u003eDrive patient adoption and procedural volume.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal Distributors\u003c\/td\u003e\n\u003ctd\u003eMarket access, inventory management, sales channels\u003c\/td\u003e\n\u003ctd\u003eInfluence regional sales performance and product availability.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch Institutions \u0026amp; Universities\u003c\/td\u003e\n\u003ctd\u003eClinical trial support, data generation, scientific validation\u003c\/td\u003e\n\u003ctd\u003eBolster product efficacy claims and surgeon confidence; STAAR University launched April 2024.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTechnology \u0026amp; Equipment Providers\u003c\/td\u003e\n\u003ctd\u003eIntegration of diagnostic\/surgical tools for ICL procedures\u003c\/td\u003e\n\u003ctd\u003eEnhance workflow efficiency and patient experience.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustry Associations (ASCRS, ESCRS)\u003c\/td\u003e\n\u003ctd\u003eTrend monitoring, technology promotion, community building\u003c\/td\u003e\n\u003ctd\u003eFacilitate market insights and professional engagement.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA detailed, data-driven representation of STAAR Surgical's business, outlining its focus on implantable Collamer lenses for refractive error correction, targeting ophthalmologists and patients seeking vision correction solutions.\u003c\/p\u003e\n\u003cp\u003eThis model emphasizes STAAR's direct sales force, partnerships with distributors, and its commitment to innovation and patient outcomes as key drivers of its success.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThe STAAR Surgical Business Model Canvas offers a clear, one-page snapshot, effectively relieving the pain of complex strategy dissection for quick understanding and alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development (R\u0026amp;D)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical's commitment to research and development is paramount, fueling continuous innovation in their implantable lens technology. This core activity involves developing new products and refining existing ones, like their Implantable Collamer Lens (ICL) portfolio.\u003c\/p\u003e\n\u003cp\u003eIn 2023, STAAR Surgical reported R\u0026amp;D expenses of $122.2 million, a significant investment demonstrating their dedication to staying ahead in the vision correction market. This focus ensures they can address a wider range of visual disorders and enhance patient outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Production\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical’s core activity involves the meticulous development, manufacturing, and marketing of its implantable lenses, primarily for vision correction. This encompasses a highly precise and complex production chain for their proprietary Collamer material, ensuring exceptional biocompatibility and optical performance.\u003c\/p\u003e\n\u003cp\u003eThe manufacturing process itself is a testament to engineering excellence, transforming raw materials through advanced techniques into sterile, high-precision lenses. This intricate journey from material processing to the final sterilization and packaging stages is critical for maintaining the quality and safety of products like the EVO Visian ICL, which is used in hundreds of thousands of procedures annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical's sales and marketing are heavily geared towards driving awareness and adoption of their EVO ICLs. This involves a direct sales force engaging with ophthalmologists and surgical centers to promote the benefits and accessibility of their lenses.\u003c\/p\u003e\n\u003cp\u003eThe company actively engages in promotional activities, including participation in industry conferences and online campaigns, to reach a wider audience of both eye care professionals and potential patients. In 2023, STAAR Surgical reported net sales of $303.4 million, reflecting their ongoing investment in these crucial business activities.\u003c\/p\u003e\n\u003cp\u003eCollaborations with ophthalmic groups are key to expanding the reach and visibility of EVO ICLs. These partnerships often involve joint marketing initiatives and educational programs designed to train surgeons and inform patients, thereby increasing the availability and uptake of the technology.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSurgeon Education and Training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSTAAR Surgical's commitment to surgeon education and training is paramount for the successful adoption of its ICL technology. This involves offering robust programs designed to build clinical confidence and ensure proficiency in implanting their lenses.\u003c\/p\u003e\n\u003cp\u003eKey initiatives like STAAR University and EVO Experience Centers provide surgeons with essential hands-on training, comprehensive digital resources, and valuable peer mentorship opportunities. These platforms are crucial for skill development and fostering a community of expert users.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eSTAAR University:\u003c\/strong\u003e Offers a structured curriculum for learning ICL implantation techniques.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEVO Experience Centers:\u003c\/strong\u003e Provide state-of-the-art facilities for practical, in-person training.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigital Resources:\u003c\/strong\u003e Include online modules, webinars, and case studies for continuous learning.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeer Mentorship:\u003c\/strong\u003e Connects experienced surgeons with those new to the technology.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Clinical Trials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSTAAR Surgical dedicates significant resources to navigating intricate global regulatory pathways, a critical activity for obtaining and sustaining market access for its implantable lenses. This involves meticulous preparation and submission of data to regulatory bodies worldwide, ensuring adherence to evolving standards.\u003c\/p\u003e\n\u003cp\u003eConducting robust clinical trials is paramount to substantiating the safety and efficacy of STAAR's products. These trials provide the scientific evidence required for regulatory approvals and ongoing market confidence. The company also engages in post-approval studies and supports independent investigator-initiated trials to further validate product performance and explore new applications.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory Approvals:\u003c\/strong\u003e STAAR Surgical's Visian ICL (Implantable Collamer Lens) has received FDA approval for various refractive error corrections, demonstrating their ability to meet stringent US regulatory requirements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobal Reach:\u003c\/strong\u003e The company actively seeks and maintains approvals in numerous international markets, including Europe, Asia, and Latin America, to support its global sales strategy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-Market Surveillance:\u003c\/strong\u003e Ongoing monitoring and data collection after product launch are key to ensuring continued safety and identifying any potential long-term effects, feeding back into product development and regulatory dialogue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePioneering Vision Correction Through Lens Innovation and R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical's key activities revolve around the innovation and precise manufacturing of their implantable lenses, notably the EVO Visian ICL. This involves substantial investment in research and development, as evidenced by their $122.2 million R\u0026amp;D expenditure in 2023, to continually enhance their product offerings and address a wider spectrum of vision correction needs.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe STAAR Surgical Business Model Canvas preview you're viewing is the actual document you will receive upon purchase. This means you're seeing a direct, unedited representation of the comprehensive analysis that will be yours to use. You'll gain full access to this same, professionally structured business model, ready for immediate application or further customization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55611319157113,"sku":"staar-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/staar-business-model-canvas.png?v=1754755238","url":"https:\/\/matrixbcg.com\/products\/staar-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}